Vaccination

Featured

Vaccination has eradicated many of the world's most deadly infectious diseases and is used to prevent childhood diseases, highly contagious diseases such as influenza, and viruses causing dangerous, chronic conditions such as hepatitis. Much of RAND's research on vaccination focuses on identifying barriers to immunization, determining strategies to promote vaccination, and studying the impact of vaccines on health in the United States and globally.

  • Vials of COVID-19 vaccine, photo by MarsBars/Getty Images

    Report

    COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year

    Oct 28, 2020

    Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.

  • The Moderna COVID-19 vaccine is administered during a drive through event at InclusivCare in Avondale, Louisiana, January 9, 2021 photo by Kathleen Flynn/Reuters

    Blog

    As the Vaccines Arrive, So Do the Questions

    Jan 11, 2021

    As the first COVID-19 vaccines are being administered across the United States, countless questions have arisen about what comes next. Is one vaccine better than another? Can the United States both speed up inoculation and overcome some people's hesitance to get the shot? RAND experts offer insights into the historic vaccine rollout.

Explore Vaccination

  • Journal Article

    Journal Article

    Use of an Electronic Monitoring System for Self-Reporting Smallpox Vaccine Reactions

    Simple-to-use telephone/Internet-based technology allowed detailed self-recording of response to smallpox vaccination among outpatients.

    Dec 31, 2004

  • Commentary

    Commentary

    Shortages Beyond Flu Shots

    The flu vaccine is not the only vaccine that Americans could find in short supply due to a lack of enough manufacturing facilities licensed by the U.S. Food and Drug Administration. In the past six years there have been U.S. shortages of more than half of the 12 recommended childhood vaccines, and there ...

    Nov 9, 2004

  • Report

    Report

    The Food and Drug Administration Confronts Homeland and National Security: Report on a Workshop of the RAND Center for Domestic and International Health Security

    Reviews a December 2002 RAND workshop on challenges the U.S. Food and Drug Administration faces, particularly in its potential responses to increased national and homeland security needs for drugs and vaccines.

    Dec 31, 2002

  • Report

    Report

    Interventions that Increase the Utilization of Medicare-Funded Preventive Services for Persons Age 65 and Older

    Reviews the evidence for effectiveness of the screening/vaccination programs currently covered by Medicare: influenza and pneumonia vaccinations, screening mammography, cervical smear cytology, and colon cancer screening.

    Dec 31, 2002

  • Journal Article

    Journal Article

    A Model for a Smallpox-Vaccination Policy

    The new reality of biologic terrorism and warfare has ignited a debate about whether to reintroduce smallpox vaccination.

    Dec 31, 2002

  • Journal Article

    Journal Article

    Interventions That Increase Use of Adult Immunization and Cancer Screening Services: A Meta-Analysis

    On the relative effectiveness of the diverse approaches used to promote preventive care activities, such as cancer screening and adult immunization.

    Dec 31, 2001

  • Journal Article

    Journal Article

    The Impact of the Vaccine for Children's Program on Child Immunization Delivery: A Policy Analysis

    The Vaccine for Children (VFC) program was proposed as part of President Clinton's 1993 Childhood Immunization Initiative.

    Dec 31, 1995

  • Content

    Content

    Laura J. Faherty

    Physician Policy Researcher; Affiliate Faculty, Pardee RAND Graduate School
    Education B.A. in history of science, Princeton University; M.D., Emory University School of Medicine; M.P.H. in global epidemiology, Emory University Rollins School of Public Health; M.S.H.P. in health policy research, University of Pennsylvania

  • Content

    Content

    Courtney A. Gidengil

    Director, Boston Office; Senior Physician Policy Researcher
    Education M.D., McGill University; M.P.H. in clinical effectiveness, Harvard School of Public Health; B.Sc. in psychology, McGill University

  • Content

    Content

    Andrew M. Parker

    Senior Behavioral and Social Scientist; Faculty, Pardee RAND Graduate School
    Education Ph.D. in behavioral decision theory, Carnegie Mellon University; M.S. in statistics, Carnegie Mellon University; B.A. in psychology and statistics, University of Michigan, Ann Arbor

  • Content

    Content

    Jeanne S. Ringel

    Director, Access and Delivery Program; Senior Economist; Professor, Pardee RAND Graduate School
    Education Ph.D. in economics, University of Maryland, College Park; M.A. in economics, University of Maryland, College Park

  • Content

    Content

    Lori Uscher-Pines

    Senior Policy Researcher; Research Quality Assurance Manager
    Education Ph.D. in health policy and management, Johns Hopkins University; M.Sc. in international relations/security studies, London School of Economics; B.A. in international relations, University of Pennsylvania

  • Content

    Content

    Raffaele Vardavas

    Mathematician; Professor, Pardee RAND Graduate School
    Education M.Sci. and Ph.D. in physics, Imperial College London

Research conducted by